Lauren P. Silvernail - 22 Jun 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Director
Signature
/s/ Lauren Silvernail by Frank J. Lanza, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
22 Jun 2023
Net transactions value
$0
Form type
4
Filing time
23 Jun 2023, 16:40:16 UTC
Previous filing
19 Sep 2022
Next filing
28 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Director Stock Option (Right to Buy) Award $0 +23,000 $0.000000 23,000 22 Jun 2023 Common Stock 23,000 $0.6657 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will fully vest and become exercisable on June 21, 2024, subject to the continuous service of the Reporting Person with the Issuer on such date.